Bristol-Myers Squibb Earnings, Revenue beat in Q4 By Investing.com

Bristol-Myers Squibb (NYSE:BMY) reported on Thursday fourth quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

Bristol-Myers Squibb announced earnings per share of $1.46 on revenue of $11.07B. Analysts polled by Investing.com anticipated EPS of $1.41 on revenue of $10.72B.

Bristol-Myers Squibb shares are down 0% from the beginning of the year and are trading at $62.03 , down-from-52-week-high.They are under-performing the S&P Global 100 which is up 2.74% from the start of the year.

Bristol-Myers Squibb follows other major Healthcare sector earnings this month

Bristol-Myers Squibb’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.

Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar